Global Drug Device Combination Products Market Growth (Status and Outlook) 2024-2030

Publication ID:

LPI05241435

Publication Date:

May 20, 2024

Pages:

112

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Combination products are therapeutic and diagnostic products that combine drugs, devices and/or biological products, leading to safer and more effective treatments thanks to careful and precise drug targeting, local administration and individualized therapy. These technologies can especially benefit patients suffering from serious diseases and conditions such as cancer, heart disease, multiple sclerosis and diabetes, among others. On the other hand, drug-device combination products have also introduced a new dynamic in medical product development, regulatory approval and corporate interaction.
The global Drug Device Combination Products market size is projected to grow from US$ 34430 million in 2023 to US$ 50080 million in 2030; it is expected to grow at a CAGR of 5.5% from 2024 to 2030.
Publisher' newest research report, the 鈥淒rug Device Combination Products Industry Forecast鈥� looks at past sales and reviews total world Drug Device Combination Products sales in 2023, providing a comprehensive analysis by region and market sector of projected Drug Device Combination Products sales for 2024 through 2030. With Drug Device Combination Products sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Device Combination Products industry.
This Insight Report provides a comprehensive analysis of the global Drug Device Combination Products landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug Device Combination Products portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Drug Device Combination Products market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Device Combination Products and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Device Combination Products.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Device Combination Products market by product type, application, key players and key regions and countries.
Segmentation by type
Drug-Eluting Stents
Prefilled Syringes
Wearable Injectors
Insulin Injector Drug
Others
Segmentation by application
Hospitals
Clinics
Ambulatory Surgical Centers
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
Terumo
Stryker
Mylan
Medtronic
Allergan,
Boston Scientific
Novartis
Teleflex
BD
W.L.Core & Associates
Gerresheimer
Schott
Nipro

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drug Device Combination Products Market Size 2019-2030
2.1.2 Drug Device Combination Products Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Drug Device Combination Products Segment by Type
2.2.1 Drug-Eluting Stents
2.2.2 Prefilled Syringes
2.2.3 Wearable Injectors
2.2.4 Insulin Injector Drug
2.2.5 Others
2.3 Drug Device Combination Products Market Size by Type
2.3.1 Drug Device Combination Products Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Drug Device Combination Products Market Size Market Share by Type (2019-2024)
2.4 Drug Device Combination Products Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Ambulatory Surgical Centers
2.4.4 Others
2.5 Drug Device Combination Products Market Size by Application
2.5.1 Drug Device Combination Products Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Drug Device Combination Products Market Size Market Share by Application (2019-2024)
3 Drug Device Combination Products Market Size by Player
3.1 Drug Device Combination Products Market Size Market Share by Players
3.1.1 Global Drug Device Combination Products Revenue by Players (2019-2024)
3.1.2 Global Drug Device Combination Products Revenue Market Share by Players (2019-2024)
3.2 Global Drug Device Combination Products Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Drug Device Combination Products by Regions
4.1 Drug Device Combination Products Market Size by Regions (2019-2024)
4.2 Americas Drug Device Combination Products Market Size Growth (2019-2024)
4.3 APAC Drug Device Combination Products Market Size Growth (2019-2024)
4.4 Europe Drug Device Combination Products Market Size Growth (2019-2024)
4.5 Middle East & Africa Drug Device Combination Products Market Size Growth (2019-2024)
5 Americas
5.1 Americas Drug Device Combination Products Market Size by Country (2019-2024)
5.2 Americas Drug Device Combination Products Market Size by Type (2019-2024)
5.3 Americas Drug Device Combination Products Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Device Combination Products Market Size by Region (2019-2024)
6.2 APAC Drug Device Combination Products Market Size by Type (2019-2024)
6.3 APAC Drug Device Combination Products Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Drug Device Combination Products by Country (2019-2024)
7.2 Europe Drug Device Combination Products Market Size by Type (2019-2024)
7.3 Europe Drug Device Combination Products Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drug Device Combination Products by Region (2019-2024)
8.2 Middle East & Africa Drug Device Combination Products Market Size by Type (2019-2024)
8.3 Middle East & Africa Drug Device Combination Products Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Drug Device Combination Products Market Forecast
10.1 Global Drug Device Combination Products Forecast by Regions (2025-2030)
10.1.1 Global Drug Device Combination Products Forecast by Regions (2025-2030)
10.1.2 Americas Drug Device Combination Products Forecast
10.1.3 APAC Drug Device Combination Products Forecast
10.1.4 Europe Drug Device Combination Products Forecast
10.1.5 Middle East & Africa Drug Device Combination Products Forecast
10.2 Americas Drug Device Combination Products Forecast by Country (2025-2030)
10.2.1 United States Drug Device Combination Products Market Forecast
10.2.2 Canada Drug Device Combination Products Market Forecast
10.2.3 Mexico Drug Device Combination Products Market Forecast
10.2.4 Brazil Drug Device Combination Products Market Forecast
10.3 APAC Drug Device Combination Products Forecast by Region (2025-2030)
10.3.1 China Drug Device Combination Products Market Forecast
10.3.2 Japan Drug Device Combination Products Market Forecast
10.3.3 Korea Drug Device Combination Products Market Forecast
10.3.4 Southeast Asia Drug Device Combination Products Market Forecast
10.3.5 India Drug Device Combination Products Market Forecast
10.3.6 Australia Drug Device Combination Products Market Forecast
10.4 Europe Drug Device Combination Products Forecast by Country (2025-2030)
10.4.1 Germany Drug Device Combination Products Market Forecast
10.4.2 France Drug Device Combination Products Market Forecast
10.4.3 UK Drug Device Combination Products Market Forecast
10.4.4 Italy Drug Device Combination Products Market Forecast
10.4.5 Russia Drug Device Combination Products Market Forecast
10.5 Middle East & Africa Drug Device Combination Products Forecast by Region (2025-2030)
10.5.1 Egypt Drug Device Combination Products Market Forecast
10.5.2 South Africa Drug Device Combination Products Market Forecast
10.5.3 Israel Drug Device Combination Products Market Forecast
10.5.4 Turkey Drug Device Combination Products Market Forecast
10.5.5 GCC Countries Drug Device Combination Products Market Forecast
10.6 Global Drug Device Combination Products Forecast by Type (2025-2030)
10.7 Global Drug Device Combination Products Forecast by Application (2025-2030)

11 Key Players Analysis
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Information
11.1.2 Abbott Laboratories Drug Device Combination Products Product Offered
11.1.3 Abbott Laboratories Drug Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Abbott Laboratories Main Business Overview
11.1.5 Abbott Laboratories Latest Developments
11.2 Terumo
11.2.1 Terumo Company Information
11.2.2 Terumo Drug Device Combination Products Product Offered
11.2.3 Terumo Drug Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Terumo Main Business Overview
11.2.5 Terumo Latest Developments
11.3 Stryker
11.3.1 Stryker Company Information
11.3.2 Stryker Drug Device Combination Products Product Offered
11.3.3 Stryker Drug Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Stryker Main Business Overview
11.3.5 Stryker Latest Developments
11.4 Mylan
11.4.1 Mylan Company Information
11.4.2 Mylan Drug Device Combination Products Product Offered
11.4.3 Mylan Drug Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Mylan Main Business Overview
11.4.5 Mylan Latest Developments
11.5 Medtronic
11.5.1 Medtronic Company Information
11.5.2 Medtronic Drug Device Combination Products Product Offered
11.5.3 Medtronic Drug Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 Medtronic Main Business Overview
11.5.5 Medtronic Latest Developments
11.6 Allergan,
11.6.1 Allergan, Company Information
11.6.2 Allergan, Drug Device Combination Products Product Offered
11.6.3 Allergan, Drug Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Allergan, Main Business Overview
11.6.5 Allergan, Latest Developments
11.7 Boston Scientific
11.7.1 Boston Scientific Company Information
11.7.2 Boston Scientific Drug Device Combination Products Product Offered
11.7.3 Boston Scientific Drug Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Boston Scientific Main Business Overview
11.7.5 Boston Scientific Latest Developments
11.8 Novartis
11.8.1 Novartis Company Information
11.8.2 Novartis Drug Device Combination Products Product Offered
11.8.3 Novartis Drug Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Novartis Main Business Overview
11.8.5 Novartis Latest Developments
11.9 Teleflex
11.9.1 Teleflex Company Information
11.9.2 Teleflex Drug Device Combination Products Product Offered
11.9.3 Teleflex Drug Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Teleflex Main Business Overview
11.9.5 Teleflex Latest Developments
11.10 BD
11.10.1 BD Company Information
11.10.2 BD Drug Device Combination Products Product Offered
11.10.3 BD Drug Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.10.4 BD Main Business Overview
11.10.5 BD Latest Developments
11.11 W.L.Core & Associates
11.11.1 W.L.Core & Associates Company Information
11.11.2 W.L.Core & Associates Drug Device Combination Products Product Offered
11.11.3 W.L.Core & Associates Drug Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.11.4 W.L.Core & Associates Main Business Overview
11.11.5 W.L.Core & Associates Latest Developments
11.12 Gerresheimer
11.12.1 Gerresheimer Company Information
11.12.2 Gerresheimer Drug Device Combination Products Product Offered
11.12.3 Gerresheimer Drug Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.12.4 Gerresheimer Main Business Overview
11.12.5 Gerresheimer Latest Developments
11.13 Schott
11.13.1 Schott Company Information
11.13.2 Schott Drug Device Combination Products Product Offered
11.13.3 Schott Drug Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.13.4 Schott Main Business Overview
11.13.5 Schott Latest Developments
11.14 Nipro
11.14.1 Nipro Company Information
11.14.2 Nipro Drug Device Combination Products Product Offered
11.14.3 Nipro Drug Device Combination Products Revenue, Gross Margin and Market Share (2019-2024)
11.14.4 Nipro Main Business Overview
11.14.5 Nipro Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂